Filter
676
Text search:
epilepsy
Featured
Recommendations
85
New Publications
137
Language
Document type
No document type
490
Guidelines
60
Studies & Reports
55
Manuals
34
Training Material
14
Strategic & Response Plan
12
Fact sheets
7
Resource Platforms
3
Situation Updates
1
Countries / Regions
India
36
South Africa
27
Kenya
21
Uganda
19
Sierra Leone
16
Malawi
16
Ethiopia
15
Zambia
13
Liberia
12
Nepal
12
Global
12
Nigeria
10
Bangladesh
9
Ghana
8
Ukraine
8
Syria
7
Lesotho
7
Tanzania
6
Latin America and the Carribbean
6
Asia
6
Eastern Europe
6
Russia
6
South Sudan
5
Cambodia
5
Rwanda
5
Mozambique
5
Western and Central Europe
5
Africa
5
Zimbabwe
4
South–East Asia Region
4
Congo, Democratic Republic of
3
Cameroon
3
Eswatini/ Swaziland
3
Botswana
3
Myanmar / Burma
3
Chile
3
Burkina Faso
2
Senegal
2
Haiti
2
Philippines
2
Pakistan
2
Afghanistan
2
China
2
Indonesia
2
Sudan
2
Namibia
2
North Macedonia
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Kazakhstan
2
Mali
1
USA
1
Germany
1
Turkey
1
Egypt
1
Thailand
1
Malaysia
1
Brazil
1
Colombia
1
Mexico
1
Sri Lanka
1
Yemen
1
East and Southern Africa
1
Fiji
1
Venezuela
1
Palestine
1
Laos
1
Lithuania
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
244
Clinical Guidelines
42
Public Health
36
Women & Child Health
21
Capacity Building
12
Key Resources
3
Pharmacy & Technologies
1
Toolboxes
Mental Health
211
Disability
132
Pharmacy
22
NTDs
20
Caregiver
15
Planetary Health
13
Conflict
8
NCDs
8
Ebola
7
Rapid Response
7
Refugee
7
Zika
7
TB
7
Global Health Education
7
COVID-19
7
HIV
6
Natural Hazards
5
AMR
4
Cholera
1
Specific Hazards
1
Q6: What is the added advantage of doing neuroimaging in people with convulsive epilepsy in non-specialist settings in low and middle income countries?
mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
Neurology Asia 2008; 13 : 41 – 48
Q 7: For adults and children with convulsive epilepsy, which standard antiepileptic drugs (phenobarbital, phenytoin, carbamazepine, valproic acid) when compared to placebo/a comparator produce benefits/harm in the specified outcomes?
Session outline
•Introduction to epilepsy.
•Assessment of epilepsy.
•Management of epilepsy.
•Follow-up of a person with
...
Lancet Neurol. 2019 Apr;18(4):357-375. doi: 10.1016/S1474-4422(18)30454-X. Epub 2019 Feb 14.
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because of the impact of epilepsy on wages, he
...
Brief review of selected topics
The following pages provide a focus on selected areas in relation to neurology. The specialists who contributed the reviews are listed in the Project Team and Partners
Neurology Atlas (2004)
DAKAR, le 06 Mai 2000
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i
...
Accessed: 10.03.2019
Lancet 2012; 380: 1193–1201
Series: Epilepsy 2
Q3: Can febrile seizures (simple or complex) be managed at first or second level care by non-specialist health care providers in low and middle income country settings? What is the role of diagnostic tests in the management of febrile seizures by non-specialists in low and middle income settings? Fo
...
Published OnlineJuly 14, 2021https://doi.org/10.1016/S2214-109X(21)00164-9. New Lancet research offers the first comprehensive analysis of the growing footprint of noncommunicable and injury-related neurological disorders to India’s overall disease burden.
Takeaways from 1990 to 2019 In terms
...
